Seelaus Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $350K | Sell |
4,471
-1,119
| -20% | -$90.3K | 0.25% | 123 |
|
|
2026
Q1 | $484K | Buy |
5,590
+250
| +5% | +$23.9K | 0.35% | 83 |
|
|
2025
Q4 | $513K | Hold |
5,340
| – | – | 0.41% | 75 |
|
|
2025
Q3 | $509K | Sell |
5,340
-90
| -2% | -$8.27K | 0.4% | 75 |
|
|
2025
Q2 | $473K | Buy |
5,430
+700
| +15% | +$59.4K | 0.42% | 72 |
|
|
2025
Q1 | $425K | Buy |
4,730
+100
| +2% | +$8.95K | 0.41% | 79 |
|
|
2024
Q4 | $370K | Hold |
4,630
| – | – | 0.34% | 92 |
|
|
2024
Q3 | $417K | Sell |
4,630
-440
| -9% | -$37K | 0.38% | 84 |
|
|
2024
Q2 | $399K | Sell |
5,070
-120
| -2% | -$9.84K | 0.4% | 79 |
|
|
2024
Q1 | $452K | Sell |
5,190
-15
| -0.3% | -$1.28K | 0.45% | 76 |
|
|
2023
Q4 | $429K | Sell |
5,205
-200
| -4% | -$15.2K | 0.42% | 84 |
|
|
2023
Q3 | $424K | Buy |
5,405
+132
| +3% | +$11.1K | 0.48% | 76 |
|
|
2023
Q2 | $465K | Buy |
5,273
+670
| +15% | +$57.7K | 0.37% | 97 |
|
|
2023
Q1 | $376K | Buy |
4,603
+1,853
| +67% | +$151K | 0.28% | 113 |
|
|
2022
Q4 | $214K | Sell |
2,750
-100
| -4% | -$8.11K | 0.16% | 173 |
|
|
2022
Q3 | $230K | Sell |
2,850
-423
| -13% | -$38K | 0.18% | 165 |
|
|
2022
Q2 | $294K | Buy |
3,273
+298
| +10% | +$30.2K | 0.22% | 143 |
|
|
2022
Q1 | $330K | Sell |
2,975
-40
| -1% | -$4.23K | 0.2% | 166 |
|
|
2021
Q4 | $312K | Sell |
3,015
-10
| -0.3% | -$1.16K | 0.17% | 174 |
|
|
2021
Q3 | $379K | Sell |
3,025
-50
| -2% | -$6.47K | 0.22% | 149 |
|
|
2021
Q2 | $382K | Buy |
3,075
+70
| +2% | +$8.79K | 0.22% | 150 |
|
|
2021
Q1 | $355K | Sell |
3,005
-240
| -7% | -$28.1K | 0.23% | 134 |
|
|
2020
Q4 | $380K | Hold |
3,245
| – | – | 0.28% | 104 |
|
|
2020
Q3 | $337K | Sell |
3,245
-40
| -1% | -$4.02K | 0.27% | 106 |
|
|
2020
Q2 | $301K | Sell |
3,285
-400
| -11% | -$38.4K | 0.27% | 107 |
|
|
2020
Q1 | $332K | Buy |
3,685
+235
| +7% | +$25K | 0.39% | 76 |
|
|
2019
Q4 | $391K | Hold |
3,450
| – | – | 0.32% | 90 |
|
|
2019
Q3 | $375K | Buy |
3,450
+155
| +5% | +$16.2K | 0.33% | 91 |
|
|
2019
Q2 | $321K | Sell |
3,295
-40
| -1% | -$3.65K | 0.29% | 94 |
|
|
2019
Q1 | $304K | Hold |
3,335
| – | – | 0.28% | 99 |
|
|
2018
Q4 | $303K | Buy |
3,335
+50
| +2% | +$4.67K | 0.32% | 90 |
|
|
2018
Q3 | $323K | Hold |
3,285
| – | – | 0.27% | 106 |
|
|
2018
Q2 | $281K | Sell |
3,285
-250
| -7% | -$20.9K | 0.24% | 110 |
|
|
2018
Q1 | $284K | Buy |
3,535
+115
| +3% | +$9.49K | 0.24% | 124 |
|
|
2017
Q4 | $276K | Buy |
+3,420
| New | +$274K | 0.24% | 126 |
|
Other funds holding MDT
FWIA
GAM
SRIM
DC
Seelaus Asset Management's MDT Position: Q2 2026 in Review
Seelaus Asset Management reduced its Medtronic (MDT) stake by 20% in Q2 2026, selling an estimated $90.3K and leaving 4,471 shares worth $350K. The position accounts for 0.25% of the portfolio, ranked #123.
Seelaus Asset Management first reported a position in MDT in Q4 2017 and has held it in 35 quarters since. The position peaked at $513K in Q4 2025. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Seelaus Asset Management held 4,471 shares of Medtronic worth $350K as of Q2 2026.
- Seelaus Asset Management sold 1,119 Medtronic shares in Q2 2026, an estimated $90.3K.
- Medtronic made up 0.25% of Seelaus Asset Management's portfolio in Q2 2026, its #123 holding.
- Seelaus Asset Management first reported a position in Medtronic in Q4 2017 and has held it in 35 quarters since.
- Seelaus Asset Management's Medtronic position peaked at $513K in Q4 2025.
- 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Seelaus Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.